New York, NY, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024”. According to the report, global multiplex biomarker imaging market was valued at approximately USD 265.9 million in 2017 and is expected to generate revenue of around USD 608.2 million by end of 2024, growing at a CAGR of around 12.3% between 2018 and 2024.
Increasing demand for analysis of the diseases and imaging has accelerated the growth of the multiplex biomarker imaging market over the estimated time.
Browse through 54 Tables & 28 Figures spread over 110 Pages and in-depth TOC on “Global Multiplex Biomarker Imaging Market Size, Share and Forecast, 2017 – 2024”.
Request Free Sample Report of Global Multiplex Biomarker Imaging Market Report @ https://www.zionmarketresearch.com/sample/multiplex-biomarker-imaging-market
The multiplex biomarker imaging market is mainly driven by its prominent characteristics such as cost-effectiveness and better analysis features which include the analysis of thousands of tissues in a single turn. Furthermore, the multiplex biomarker imaging market is driven by the upsurge demand for clinical diagnostics due to the invasion of chronic diseases. The multiplex biomarker imaging is a significant tool as they provide the expression of appropriate targetable surface markers, hemoglobin status, detection of exact tumor location, documentation of drug delivery, the presence of apoptosis, etc. However, the complex process and the ethical issues involved along with the stringent policies of the government are acting as the restraint for the multiplex biomarker imaging market and may affect its growth in the long term. Nonetheless, reagent has significant potential for the anticancer drug discovery by detecting the proteins that are prominent for regulating protein networks, which is likely to disclose the new avenues for the market.
Global multiplex biomarker imaging market is divided into its application, imaging techniques, and end-user. On the basis of the application, the market is divided into drug safety, oncology studies, and genetic characterization studies.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/multiplex-biomarker-imaging-market
Based on imaging techniques multiplex biomarker imaging market is categorized into immunofluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in the situ hybridization (FISH) assay, and toponome imaging system (TIS).
On the basis of the end user, the multiplex biomarker imaging market is segregated as research institutes government & private, clinical labs, and pharmaceutical & biotechnology.
Request for Discount: https://www.zionmarketresearch.com/requestdiscount/multiplex-biomarker-imaging-market
In the multiplex biomarker imaging market, North America is anticipated to hold the prominent market value share over the forecast period. The U.S. is by far the leading multiplex biomarker imaging market by country in North America. The U.S. market is anticipated to grow with significant CAGR over the near future. Increasing cancer cases is supporting the growth of multiplex biomarker imaging market in North America.
North America is anticipated to be followed by Europe and is expected to show a significant growth in the near future. This growth is mainly driven by the upsurge need of the reagent which provides significant & cost-effective analysis of diseases. Increasing cases of chronic diseases are increasing the demand for the multiplex biomarker imaging market.
Browse the full "Multiplex Biomarker Imaging Market by Application (Drug Safety, Oncology Studies, and Genetic Characterization Studies), by Imaging Techniques (Immuno Fluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent in the Situ Hybridization (FISH) Assay, and Toponome Imaging System (TIS)), and by End-User (Research Institutes Government & Private, Clinical Labs, and Pharmaceutical & Biotechnology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024" report at https://www.zionmarketresearch.com/report/multiplex-biomarker-imaging-market
The Asia Pacific is expected to witness the highest growth rate in the near future. Developing and developed countries of Asia Pacific, such as India, China, and Japan is expected to show a significant growth in the multiplex biomarker imaging market. Growth in the Asia Pacific market is supported by the large patient pool suffering from chronic diseases and the on-going researches for their base treatment.
The Middle East & Africa region is anticipated to register low to moderate growth rate due to low per capita income which results in the lack of accessibility to the multiplex biomarker imaging. Latin America is another prominent region witnessing the moderate growth in multiplex biomarker imaging market.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/multiplex-biomarker-imaging-market
Some of the key players in multiplex biomarker imaging market include Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abcam Plc., US Biomax Inc., Merck KGaA, ToposNomos Ltd., MicroConstants, Inc., Aushon BioSystems Ltd., Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Illumina Inc., and others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/1670
This report segments the global multiplex biomarker imaging market as follows:
Global Multiplex Biomarker Imaging Market: By Application
- Drug Safety
- Oncology Studies
- Genetic Characterization Studies
Global Multiplex Biomarker Imaging Market: By Imaging Techniques
- Immuno Fluorescence (IF) Assay
- Tissue Microarray (TMA) Assay
- Immunohistochemistry (IHC) Assay
- Fluorescent in the Situ Hybridization (FISH) Assay
- Toponome Imaging System (TIS)
Global Multiplex Biomarker Imaging Market: By End-User
- Research Institutes Government & Private
- Clinical Labs
- Pharmaceutical & Biotechnology
Global Multiplex Biomarker Imaging Market: By Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Browse More Related Reports:
- Scleroderma Diagnostics and Therapeutics Market: https://www.zionmarketresearch.com/report/scleroderma-diagnostics-and-therapeutics-market
- Laboratory Information Systems (LIS) Market: https://www.zionmarketresearch.com/report/laboratory-information-systems-market
- Stem Cell Therapy Market: https://www.zionmarketresearch.com/report/stem-cell-therapy-market
- In Vivo Toxicology Market: https://www.zionmarketresearch.com/report/in-vivo-toxicology-market
- Veterinary Imaging Market: https://www.zionmarketresearch.com/report/veterinary-imaging-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com